SAXAGLIPTIN+DAPAGLIFLOZIN
About SAXAGLIPTIN+DAPAGLIFLOZIN
SAXAGLIPTIN+DAPAGLIFLOZIN belongs to the group of anti-diabetic medicines used to treat type-2 diabetes mellitus adjunct to diet and exercise. Type-2 diabetes mellitus is also known as non-insulin-dependent diabetes or adult-onset diabetes. SAXAGLIPTIN+DAPAGLIFLOZIN is not indicated to treat diabetic ketoacidosis or type-1 diabetes mellitus.
SAXAGLIPTIN+DAPAGLIFLOZIN is a combination of two drugs, namely: Saxagliptin (dipeptidyl peptidase-4 inhibitor) and Dapagliflozin (sodium-glucose cotransporter-2 inhibitors). Saxagliptin enhances glucose-mediated insulin secretion, thereby reduces fasting and post-prandial blood sugar concentrations. Dapagliflozin removes excess sugar from the body via urine. Together, SAXAGLIPTIN+DAPAGLIFLOZIN helps treat type-2 diabetes mellitus.
You are advised to take SAXAGLIPTIN+DAPAGLIFLOZIN for as long as your doctor has prescribed it for you, depending on your medical condition. In some cases, you may experience certain common side effects such as urinary tract infection, hypoglycaemia, upper respiratory tract infection, and dyslipidaemia. You are advised to consult your doctor if the side effects persist or worsen.
Avoid taking SAXAGLIPTIN+DAPAGLIFLOZIN if you are pregnant or breastfeeding. SAXAGLIPTIN+DAPAGLIFLOZIN is not recommended for children below 18 years as safety and effectiveness have not been established. Avoid alcohol consumption while taking SAXAGLIPTIN+DAPAGLIFLOZIN as it might cause unpleasant side-effects. Inform your doctor about all the medicines you are taking and your health condition to rule out any unpleasant side effects/interactions.
Uses of SAXAGLIPTIN+DAPAGLIFLOZIN
Medicinal Benefits
SAXAGLIPTIN+DAPAGLIFLOZIN is a combination of two drugs, namely: Saxagliptin and Dapagliflozin. SAXAGLIPTIN+DAPAGLIFLOZIN belongs to the group of anti-diabetic medicines used to treat type-2 diabetes mellitus adjunct to diet and exercise. Saxagliptin is a dipeptidyl peptidase-4 inhibitor that enhances glucose-mediated insulin secretion, thereby reducing fasting and post-prandial blood sugar concentrations. Dapagliflozin is a sodium-glucose cotransporter 2 inhibitor that removes excess sugar from the body via urine. Together, SAXAGLIPTIN+DAPAGLIFLOZIN helps treat type-2 diabetes mellitus.
Directions for Use
Storage
Side Effects of SAXAGLIPTIN+DAPAGLIFLOZIN
- Urinary tract infection
- Hypoglycaemia (low blood glucose levels)
- Upper respiratory tract infection
- Dyslipidaemia (high levels of lipids)
Patients Concern
Disease/Condition Glossary
Type-2 diabetes mellitus: It is also known as non-insulin-dependent diabetes. It is a chronic or lifelong disease that keeps the body from utilizing insulin properly. Diabetes is a medical condition in which blood glucose levels are above normal. People with type 2 diabetes either do not produce enough insulin, or the insulin produced cannot perform its function in the body (insulin resistance). Middle-aged or older individuals are most likely to suffer from type 2 diabetes; hence it is also known as adult-onset diabetes. Type 2 diabetes symptoms include lack of energy, tiredness, frequent urination, excess thirst, dry mouth, blurry vision, constant hunger, weight loss, and itchy skin.
FAQs
SAXAGLIPTIN+DAPAGLIFLOZIN contains Saxagliptin and Dapagliflozin. Saxagliptin enhances glucose-mediated insulin secretion, thereby reduces fasting and post-prandial blood sugar concentrations. Dapagliflozin removes excess sugar from the body via urine. Together, SAXAGLIPTIN+DAPAGLIFLOZIN helps treat type-2 diabetes mellitus.
Do not stop taking SAXAGLIPTIN+DAPAGLIFLOZIN without consulting your doctor, as it may cause an increase in blood glucose levels. Continue taking SAXAGLIPTIN+DAPAGLIFLOZIN for as long as your doctor has prescribed it to you. Do not be reluctant to speak with your doctor if you experience any difficulty while taking SAXAGLIPTIN+DAPAGLIFLOZIN.
Dehydration could be a side-effect of SAXAGLIPTIN+DAPAGLIFLOZIN. Drink plenty of fluids if you experience any symptoms of dehydration such as dry mouth, feeling thirsty, tiredness, sleepiness, passing less urine, and fast heartbeat.
SAXAGLIPTIN+DAPAGLIFLOZIN may sometimes lower the blood glucose levels more than normal, leading to hypoglycemia. Regularly monitor your blood sugar levels while taking SAXAGLIPTIN+DAPAGLIFLOZIN. Hypoglycemia symptoms include headache, dizziness, drowsiness, shakiness, faintness, confusion, and visual disturbances.
Maintain a healthy diet by regular intake of carbohydrates. Eat your meals regularly, and do not exercise heavily for longer durations with an empty stomach.
